Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine on Skeletal Muscle Endpoints in Angina and PAD
NCT00657514Phase 4Withdrawn
- Sponsor
- CPC Clinical Research
- Start
- May 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in Peripheral Arterial Disease (PAD), sponsored by CPC Clinical Research. Planned start May 2008; status: withdrawn.
02
Drugs
ranolazine
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00657514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657514.